NCI-H2122 In Vitro High Content Screening (HCS) Assay

CAT#: ITS-0123-YF1461
Target Cell Organism: Human
Target Cell Alternative Name: H2122
Target Cell Name: NCI-H2122
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide NCI-H2122-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H2122
Target Cell Organism
Human
Target Cell Background
NCI-H2122 [H2122] cells are lymphoblasts isolated in 1989 from a pleural effusion metastasis derived from a 46-year-old female smoker. Use these cells in lung cancer research.
Target Cell Alternative Name
H2122
Related Diseases
Non Small Cell Lung Cancer
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry